fda and tirzepatide approval for Zepbound (tirzepatide) injection, the first only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly FDA says the tirzepatide weight-loss
Description
Our goal is to be there for every moment, and this is a prime example of our work to deliver for our consumers wherever they need us to be.
Furthermore, under clinical trial conditions Wegovy and tirzapetide continued to deliver significant, incremental weight loss until week 48, and even beyond for higher doses14
Creatine monohydrate shows promise in helping retain lean mass during GLP-1 therapy
Keep easy options available, such as yogurt, eggs, soups, smoothies, or ready-to-drink nutrition shakes
